Malignant Mesothelioma Market Report 2026
Download Free Sample Buy Now
Malignant Mesothelioma Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Malignant Mesothelioma Market Report 2026

Global Outlook – By Treatment Type (Chemotherapy, Radiation Therapy, Surgery, Immunotherapy, Targeted Therapy), By Route Of Administration (Oral, Intravenous, Injectable), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies), By End-User (Hospitals, Oncology Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Malignant Mesothelioma Market Overview

• Malignant Mesothelioma market size has reached to $2.61 billion in 2025

• Expected to grow to $3.53 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%

• Growth Driver: Increase In Clinical Research And Development Efforts Fueling The Growth Of The Market Due To Advancements In Diagnostics And Treatment Options

• Market Trend: Monoclonal Antibodies Drive Innovation In Malignant Mesothelioma Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Malignant Mesothelioma Market?

Malignant mesothelioma is a rare and aggressive type of cancer that primarily affects the mesothelium, a thin layer of tissue that covers most of the internal organs. It most commonly develops in the lining of the lungs (pleura) but can also occur in the lining of the abdomen (peritoneum), heart (pericardium), or testicles. The main risk factor for developing malignant mesothelioma is exposure to asbestos, a mineral once widely used in construction and manufacturing.

The main types of malignant mesothelioma are chemotherapy, radiation therapy, surgery, immunotherapy, and targeted therapy. Chemotherapy for malignant mesothelioma is a treatment that uses drugs to kill cancer cells, slow tumor growth, and help manage symptoms. It is often used when mesothelioma has spread beyond where surgery alone can be effective. The various routes of administration involved are oral, intravenous, injectable, and topical. The distribution channels involved are hospital pharmacies, retail pharmacies, online pharmacies, and specialty pharmacies, which hospitals, oncology clinics, Rehabilitation centers, and research laboratories use.

Malignant Mesothelioma Market Global Report 2026 Market Report bar graph

What Is The Malignant Mesothelioma Market Size and Share 2026?

The malignant mesothelioma market size has grown strongly in recent years. It will grow from $2.61 billion in 2025 to $2.77 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to historical asbestos exposure in construction and manufacturing, long disease latency period, limited early treatment options, increasing occupational health awareness, gradual improvement in diagnostic imaging.

What Is The Malignant Mesothelioma Market Growth Forecast?

The malignant mesothelioma market size is expected to see strong growth in the next few years. It will grow to $3.53 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to advancements in immunotherapy and targeted drugs, rising investment in rare cancer research, growing number of clinical trials, improved diagnostic technologies, increasing healthcare spending on oncology. Major trends in the forecast period include growing adoption of immunotherapy and targeted therapy, rising focus on multimodal treatment approaches, increasing demand for early and accurate diagnosis, expansion of specialized mesothelioma treatment centers, higher participation in clinical trials for rare cancers.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Malignant Mesothelioma Market Segmentation

1) By Treatment Type: Chemotherapy, Radiation Therapy, Surgery, Immunotherapy, Targeted Therapy

2) By Route Of Administration: Oral, Intravenous, Injectable

3) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies

4) By End-User: Hospitals, Oncology Clinics

Subsegments:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Combination Therapy

2) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), Proton Therapy

3) By Surgery: Pleurectomy Or Decortication (P/D), Extrapleural Pneumonectomy (EPP), Cytoreductive Surgery, Palliative Surgery

4) By Immunotherapy: Immune Checkpoint Inhibitors, Monoclonal Antibodies, Tumor Vaccines, Adoptive Cell Therapy

5) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs), Angiogenesis Inhibitors, Mesothelin-Targeted Agents, Gene Therapy-Based Approaches

What Is The Driver Of The Malignant Mesothelioma Market?

The increasing clinical research and development efforts are expected to drive the growth of the malignant mesothelioma market going forward. Clinical research and development (R&D) efforts involve conducting scientific studies and trials to develop new drugs, treatments, and medical devices. These efforts include testing new products' safety, efficacy, and potential side effects through controlled clinical trials. The increasing clinical research and development efforts are due to the growing demand for new and improved treatments, especially with the rising prevalence of chronic diseases and complex conditions. Research and development efforts drive malignant mesothelioma by accelerating advances in diagnostics, treatments, and targeted therapies, fostering innovative approaches to improve early detection, enhance survival rates, and develop more effective, less invasive treatment options. For instance, in January 2025, according to Anadolu Agency, a Turkey-based state-run news agency, clinical trials make up nearly 40% of the U.S. pharmaceutical research budget, totaling approximately $7 billion annually. Therefore, the increasing research and development efforts are driving the growth of the malignant mesothelioma industry.

Key Players In The Global Malignant Mesothelioma Market

Major companies operating in the malignant mesothelioma market are AstraZeneca PLC, Bristol Myers Squibb Company, Merck & Co. Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., Eli Lilly and Company, Johnson & Johnson, AbbVie Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Gilead Sciences Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Bayer AG, Eisai Co. Ltd., Astellas Pharma Inc., Ono Pharmaceutical Co. Ltd., PharmaMar S.A.

Global Malignant Mesothelioma Market Trends and Insights

Major companies operating in the malignant mesothelioma market are focusing on developing advanced treatment options, such as monoclonal antibody treatments, to inhibit tumor growth and improve treatment precision. Monoclonal antibodies refer to laboratory-made proteins that mimic the immune system's ability to detect and target specific antigens, such as those found on cancer cells. For instance, in November 2023, Ono Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company, received supplemental approval in Japan for the expanded use of Opdivo (nivolumab), a human anti-human PD-1 monoclonal antibody for the treatment of malignant mesothelioma (excluding malignant pleural mesothelioma). This approval marks Opdivo as a new treatment option for this condition, where no standard treatments were previously established. Opdivo was designated an orphan drug for this indication, highlighting its potential to address a significant medical need.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Malignant Mesothelioma Market?

In February 2024, AstraZeneca, a UK-based pharmaceutical company, acquired Gracell Biotechnologies for $1.2 billion. With this acquisition, AstraZeneca will take over all of Gracell's fully diluted share capital, including the shares represented by American depositary shares. Gracell Biotechnologies is a China-based that specializes in developing innovative cell therapies for cancer and autoimmune diseases, including malignant mesothelioma.

Regional Outlook

North America was the largest region in the malignant mesothelioma market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Malignant Mesothelioma Market?

The malignant mesothelioma market consists of revenues earned by entities by providing services such as genetic testing and biomarker analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The malignant mesothelioma market includes sales of radiation therapy equipment, biopsy kits, diagnostic imaging systems, genetic testing kits, and home healthcare equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Malignant Mesothelioma Market Report 2026?

The malignant mesothelioma market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the malignant mesothelioma industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Malignant Mesothelioma Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.77 billion
Revenue Forecast In 2035 $3.53 billion
Growth Rate CAGR of 6.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment Type, Route Of Administration, Distribution Channel, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled AstraZeneca PLC, Bristol Myers Squibb Company, Merck & Co. Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., Eli Lilly and Company, Johnson & Johnson, AbbVie Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Gilead Sciences Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Bayer AG, Eisai Co. Ltd., Astellas Pharma Inc., Ono Pharmaceutical Co. Ltd., PharmaMar S.A.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Malignant Mesothelioma Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Malignant Mesothelioma Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Malignant Mesothelioma Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Malignant Mesothelioma Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Adoption Of Immunotherapy And Targeted Therapy

4.2.2 Rising Focus On Multimodal Treatment Approaches

4.2.3 Increasing Demand For Early And Accurate Diagnosis

4.2.4 Expansion Of Specialized Mesothelioma Treatment Centers

4.2.5 Higher Participation In Clinical Trials For Rare Cancers

5. Malignant Mesothelioma Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Clinics

5.3 Rehabilitation Centres

5.4 Research Laboratories

5.5 Others

6. Malignant Mesothelioma Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Malignant Mesothelioma Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Malignant Mesothelioma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Malignant Mesothelioma Market Size, Comparisons And Growth Rate Analysis

7.3. Global Malignant Mesothelioma Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Malignant Mesothelioma Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Malignant Mesothelioma Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Malignant Mesothelioma Market Segmentation

9.1. Global Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemotherapy, Radiation Therapy, Surgery, Immunotherapy, Targeted Therapy

9.2. Global Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Intravenous, Injectable

9.3. Global Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Specialty Pharmacies

9.4. Global Malignant Mesothelioma Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Oncology Clinics

9.5. Global Malignant Mesothelioma Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Alkylating Agents, Antimetabolites, Combination Therapy

9.6. Global Malignant Mesothelioma Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

External Beam Radiation Therapy (EBRT), Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), Proton Therapy

9.7. Global Malignant Mesothelioma Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pleurectomy Or Decortication (P/D), Extrapleural Pneumonectomy (EPP), Cytoreductive Surgery, Palliative Surgery

9.8. Global Malignant Mesothelioma Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immune Checkpoint Inhibitors, Monoclonal Antibodies, Tumor Vaccines, Adoptive Cell Therapy

9.9. Global Malignant Mesothelioma Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tyrosine Kinase Inhibitors (TKIs), Angiogenesis Inhibitors, Mesothelin-Targeted Agents, Gene Therapy-Based Approaches

10. Malignant Mesothelioma Market Regional And Country Analysis

10.1. Global Malignant Mesothelioma Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Malignant Mesothelioma Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Malignant Mesothelioma Market

11.1. Asia-Pacific Malignant Mesothelioma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Malignant Mesothelioma Market

12.1. China Malignant Mesothelioma Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Malignant Mesothelioma Market

13.1. India Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Malignant Mesothelioma Market

14.1. Japan Malignant Mesothelioma Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Malignant Mesothelioma Market

15.1. Australia Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Malignant Mesothelioma Market

16.1. Indonesia Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Malignant Mesothelioma Market

17.1. South Korea Malignant Mesothelioma Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Malignant Mesothelioma Market

18.1. Taiwan Malignant Mesothelioma Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Malignant Mesothelioma Market

19.1. South East Asia Malignant Mesothelioma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Malignant Mesothelioma Market

20.1. Western Europe Malignant Mesothelioma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Malignant Mesothelioma Market

21.1. UK Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Malignant Mesothelioma Market

22.1. Germany Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Malignant Mesothelioma Market

23.1. France Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Malignant Mesothelioma Market

24.1. Italy Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Malignant Mesothelioma Market

25.1. Spain Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Malignant Mesothelioma Market

26.1. Eastern Europe Malignant Mesothelioma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Malignant Mesothelioma Market

27.1. Russia Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Malignant Mesothelioma Market

28.1. North America Malignant Mesothelioma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Malignant Mesothelioma Market

29.1. USA Malignant Mesothelioma Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Malignant Mesothelioma Market

30.1. Canada Malignant Mesothelioma Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Malignant Mesothelioma Market

31.1. South America Malignant Mesothelioma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Malignant Mesothelioma Market

32.1. Brazil Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Malignant Mesothelioma Market

33.1. Middle East Malignant Mesothelioma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Malignant Mesothelioma Market

34.1. Africa Malignant Mesothelioma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Malignant Mesothelioma Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Malignant Mesothelioma Market Regulatory and Investment Landscape

36. Malignant Mesothelioma Market Competitive Landscape And Company Profiles

36.1. Malignant Mesothelioma Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Malignant Mesothelioma Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Malignant Mesothelioma Market Company Profiles

36.3.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Malignant Mesothelioma Market Other Major And Innovative Companies

Pfizer Inc., Eli Lilly and Company, Johnson & Johnson, AbbVie Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Gilead Sciences Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Bayer AG, Eisai Co. Ltd., Astellas Pharma Inc., Ono Pharmaceutical Co. Ltd., PharmaMar S.A.

38. Global Malignant Mesothelioma Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Malignant Mesothelioma Market

40. Malignant Mesothelioma Market High Potential Countries, Segments and Strategies

40.1 Malignant Mesothelioma Market In 2030 - Countries Offering Most New Opportunities

40.2 Malignant Mesothelioma Market In 2030 - Segments Offering Most New Opportunities

40.3 Malignant Mesothelioma Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Malignant Mesothelioma Market, Overview Of Key Products - Product Examples
  • Table 2: Global Malignant Mesothelioma Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Malignant Mesothelioma Market, Supply Chain Analysis
  • Table 4: Global Malignant Mesothelioma Market, Major Raw Material Providers
  • Table 5: Global Malignant Mesothelioma Market, Major Resource Providers
  • Table 6: Global Malignant Mesothelioma Market, Major Manufacturers (Suppliers)
  • Table 7: Global Malignant Mesothelioma Market, Major Distributors And Channel Partners
  • Table 8: Global Malignant Mesothelioma Market, Key Technologies & Future Trends
  • Table 9: Global Malignant Mesothelioma Market, Major Trends
  • Table 10: Global Malignant Mesothelioma Market, Major End Users
  • Table 11: Global Malignant Mesothelioma Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Malignant Mesothelioma Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Malignant Mesothelioma Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Malignant Mesothelioma Market - TAM, US$ Billion, 2025
  • Table 15: Global Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Malignant Mesothelioma Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Malignant Mesothelioma Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Malignant Mesothelioma Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Malignant Mesothelioma Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Malignant Mesothelioma Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Malignant Mesothelioma Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Malignant Mesothelioma Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Malignant Mesothelioma Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Malignant Mesothelioma Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Malignant Mesothelioma Market - Company Scoring Matrix
  • Table 100: AstraZeneca PLC Financial Performance
  • Table 101: Bristol Myers Squibb Company Financial Performance
  • Table 102: Merck & Co. Inc. Financial Performance
  • Table 103: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 104: Novartis AG Financial Performance
  • Table 105: Global Malignant Mesothelioma Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Malignant Mesothelioma Market, Competitive Dashboard
  • Table 107: Global Malignant Mesothelioma Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Malignant Mesothelioma Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Table 109: Global, Malignant Mesothelioma Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 110: Global, Malignant Mesothelioma Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Malignant Mesothelioma Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Malignant Mesothelioma Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Malignant Mesothelioma Market, Supply Chain Analysis
  • Figure 4: Global Malignant Mesothelioma Market, Major Raw Material Providers
  • Figure 5: Global Malignant Mesothelioma Market, Major Resource Providers
  • Figure 6: Global Malignant Mesothelioma Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Malignant Mesothelioma Market, Major Distributors And Channel Partners
  • Figure 8: Global Malignant Mesothelioma Market, Key Technologies & Future Trends
  • Figure 9: Global Malignant Mesothelioma Market, Major Trends
  • Figure 10: Global Malignant Mesothelioma Market, Major End Users
  • Figure 11: Global Malignant Mesothelioma Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Malignant Mesothelioma Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Malignant Mesothelioma Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Malignant Mesothelioma Market - TAM, US$ Billion, 2025
  • Figure 15: Global Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Malignant Mesothelioma Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Malignant Mesothelioma Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Malignant Mesothelioma Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Malignant Mesothelioma Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Malignant Mesothelioma Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Malignant Mesothelioma Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Malignant Mesothelioma Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Malignant Mesothelioma Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Malignant Mesothelioma Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Malignant Mesothelioma Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Malignant Mesothelioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Malignant Mesothelioma Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Malignant Mesothelioma Market - Company Scoring Matrix
  • Figure 100: AstraZeneca PLC Financial Performance
  • Figure 101: Bristol Myers Squibb Company Financial Performance
  • Figure 102: Merck & Co. Inc. Financial Performance
  • Figure 103: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 104: Novartis AG Financial Performance
  • Figure 105: Global Malignant Mesothelioma Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Malignant Mesothelioma Market, Competitive Dashboard
  • Figure 107: Global Malignant Mesothelioma Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Malignant Mesothelioma Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Figure 109: Global, Malignant Mesothelioma Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 110: Global, Malignant Mesothelioma Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Coxsackievirus Infections Treatment Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Read More About Coxsackievirus Infections Treatment Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Cranial Fixation System Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Read More About Cranial Fixation System Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Crow's Feet Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Read More About Crow's Feet Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Cutaneous Squamous Cell Carcinoma (cSCC) Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Cutaneous Squamous Cell Carcinoma (cSCC) Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Glioblastoma Multiforme Market Report 2026 - Global Outlook – By Drug Class (Chemotherapy Agents, Temozolomide, Carmustine, Lomustine, Other Drug Classes), By Diagnostic Tools (Magnetic Resonance Imaging (MRI), Computed ...

Acoustic Neuroma Market Report 2026 - Global Outlook – By Type (Unilateral Vestibular Schwannomas, Bilateral Vestibular Schwannomas), By Treatment Type (Radiation Therapy, Proton Therapy, Stereotactic Radiosurgery), By D...

Paraganglioma Market Report 2026 - Global Outlook – By Type (Sympathetic Paragangliomas, Parasympathetic Paragangliomas, Carotid Paragangliomas, Cervical Paragangliomas, Jugular Paragangliomas, Secretory Paragangliomas, ...

Adult Malignant Glioma Therapeutics Market Report 2026 - Global Outlook – By Type Of Disease (Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Other Types), By T...

Glioma Treatment Market Report 2026 - Global Outlook – By Type (Low-Grade, High-Grade), By Disease (Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Other Diseases), By Route Of Administrati...

Medulloblastoma Drug Market Report 2026 - Global Outlook – By Drug Candidate (Dianhydrogalactitol, Investigational Medicinal Product 5471, Ipilimumab, Indoximod, Other Types), By Product (Chemotherapy Drugs, Targeted The...

Tumor Ablation Market Report 2026 - Global Outlook – By Type (Thermal Ablation, Chemical Ablation), By Types Of Treatment (Percutaneous, Laparoscopic, Surgical), By Application (Kidney Cancer, Liver Cancer, Breast Cancer...

Anaplastic Astrocytoma Market Report 2026 - Global Outlook – By Treatment Type (Surgery, Chemotherapy, Radiation Therapy), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Specialty Cancer Centers) ...

Frequently Asked Questions

The Malignant Mesothelioma market was valued at $2.61 billion in 2025, increased to $2.77 billion in 2026, and is projected to reach $3.53 billion by 2030.

The global Malignant Mesothelioma market is expected to grow at a CAGR of 6.3% from 2026 to 2035 to reach $3.53 billion by 2035.

Some Key Players in the Malignant Mesothelioma market Include, AstraZeneca PLC, Bristol Myers Squibb Company, Merck & Co. Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., Eli Lilly and Company, Johnson & Johnson, AbbVie Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Gilead Sciences Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Bayer AG, Eisai Co. Ltd., Astellas Pharma Inc., Ono Pharmaceutical Co. Ltd., PharmaMar S.A. .

Major trend in this market includes: Monoclonal Antibodies Drive Innovation In Malignant Mesothelioma Treatment. For further insights on this market. request a sample here

North America was the largest region in the malignant mesothelioma market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malignant mesothelioma market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us